Irrimax Corporation is focused on treating and preventing infections, reducing healthcare costs, improving patient outcomes and increasing the safety of healthcare professionals.Innovation Technologies, Inc., parent company to Irrimax Corporation, holds the rights to US and worldwide patents that provide broad protection for the use oflow-concentration CHG (1% or less) technology. The company’s flagship product, Irrisept, is jet lavage containing low concentration Chlorhexidine Gluconate (CHG) 0.05% in sterile water for irrigation.Irrimax has attracted experts in the fields of product development, clinical research, manufacturing and distribution. Their management team is committed to leading the organization according to high standards of integrity and accountability. Irrimax Corporation is focused on driving innovation and improving patient outcomes.

Irrimax Corporation

Mark Alvarez

Robert Woodward

Todd Stein

Tina King Msn Rn, Cnor

Michael Gil

Sharon Klinck

Venkata Katragadda

Chavarous Kennebrew

The Marketing and Sales team at Irrimax Corporation is responsible for promoting the company's innovative infection treatment solutions, particularly the flagship product, Irrisept. This team develops strategic marketing initiatives, manages relationships with distributors, and engages with healthcare professionals to effectively communicate the benefits of low-concentration CHG technology. Their efforts aim to drive product adoption, enhance market presence, and ultimately improve patient outcomes and safety in healthcare settings.

Marketing and Sales

Sales Team

Leadership Team

Operations and Compliance

Marketing and Sales

About

Team members

Other teams at Irrimax Corporation

Sales Team

Leadership Team

Operations and Compliance